KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
Conditions:   Cancer;   Predictive Cancer Model;   Effects of Chemotherapy
Intervention:   Diagnostic Test: Known 3Dx Test
Sponsors:   Known Medicine, Inc.;   M.D. Anderson Cancer Center;   Duke Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 21, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments